Back to results
US 2008/0306067 A1Published application
Modulators of Chemokine Receptor Activity
OwnerKlaus Weigand, Thomas Ullrich +3inventors
InventorsKlaus Weigand, Thomas Ullrich, Kate Hoeganauer, Philipp Lehr, Rohan Beckwith
Life of this patent
Estimating the term…
Abstract
A compound of formula (I), wherein substituents are as given above, useful in the treatment of a disease mediated by the action of CCR3, in particular inflammatory or obstructive airway diseases.
Claims19
A compound of formula
- wherein
- X is (C6-18)aryl substituted one or more times by halogen, cyano, hydroxy, carboxy, nitro,
- (C1-8)alkyl, (C1-8)alkoxy, (C3-8)cycloalkyl, (C3-8)cycloalkyl(C1-4)alkoxy or (C1-8)alkylamine, or unsubstituted or substituted (C6-18)aryl annelated with (C3-8)cycloalkyl,
- R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen, cyano, hydroxy, carboxy, nitro, (C1-8)alkyl and (C1-8)alkoxy,
- Ra is (C1-4)alkyl, (C3-8)cycloalkyl,
- n is zero or an integer from 1 to 8,
- is a single bond, a double bond, (C3-8)cycloalkyl or absent,
- z is an integer from 1 to 5,
- Y is a cyclic group selected from the group consisting of (C6-18)aryl and an optionally
- annelated 5 to 6 membered heterocyclic ring system, wherein at least one of the ring atoms is selected from N, O or S, said cyclic group being substituted one or more times by
- halogen, (C1-8)alkyl, (C3-8)cycloalkyl, hydroxyl(C1-4)alkyl, (C1-8)alkoxycarbonyl, hydroxycarbonyl, (C1-4)alkylcarbonylamino, (C1-4)alkylaminocarbonyl, di(C1-4)alkylaminocarbonyl, (C6-18)arylaminocarbonyl, (C6-18)aryl(C1-2)alkylaminocarbonyl, (C1-4)alkylamino(C1-4)alkylaminocarbonyl, di(C1-4)alkylamino(C1-4)alkylaminocarbonyl, (C3-6)cycloalkyl(C1-4)alkylaminocarbonyl, (C6-18)arylaminocarbonyl, (C6-18)aryl(C1-4)alkylaminocarbonyl,
- heterocyclyl(C1-4)alkyl or heterocyclylcarbonyl, wherein heterocyclyl is a 5 to 6 membered heterocyclic ring system, wherein at least one of the ring atoms is selected from N, O or S,
- (C6-18)aryl, or by an unsubstituted or substituted optionally annelated 5 to 6 membered heterocyclic ring system, wherein at least one of the ring atoms is selected from N, O or S.
10 more elements
5-6. (canceled)
Dependencies are inferred from the claim text.